Title 42

PART 447 SUBPART I

Subpart I - Payment for Drugs Source:81 FR 5347, Feb. 1, 2016, unless otherwise noted.

• 42 U.S.C. 1302 and 1396r-8.
• Source: 43 FR 45253, Sept. 29, 1978, unless otherwise noted.

42:4.0.1.1.12.9.118.1	SECTION 447.500	447.500 Basis and purpose.
42:4.0.1.1.12.9.118.2	SECTION 447.502	447.502 Definitions.
42:4.0.1.1.12.9.118.3	SECTION 447.504	447.504 Determination of average manufacturer price.
42:4.0.1.1.12.9.118.4	SECTION 447.505	447.505 Determination of best price.
42:4.0.1.1.12.9.118.5	SECTION 447.506	447.506 Authorized generic drugs.
42:4.0.1.1.12.9.118.6	SECTION 447.507	447.507 Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs).
42:4.0.1.1.12.9.118.7	SECTION 447.508	447.508 Exclusion from best price of certain sales at a nominal price.
42:4.0.1.1.12.9.118.8	SECTION 447.509	447.509 Medicaid drug rebates (MDR).
42:4.0.1.1.12.9.118.9	SECTION 447.510	447.510 Requirements for manufacturers.
42:4.0.1.1.12.9.118.10	SECTION 447.511	447.511 Requirements for States.
42:4.0.1.1.12.9.118.11	SECTION 447.512	447.512 Drugs: Aggregate upper limits of payment.
42:4.0.1.1.12.9.118.12	SECTION 447.514	447.514 Upper limits for multiple source drugs.
42:4.0.1.1.12.9.118.13	SECTION 447.516	447.516 Upper limits for drugs furnished as part of services.
42:4.0.1.1.12.9.118.14	SECTION 447.518	447.518 State plan requirements, findings, and assurances.
42:4.0.1.1.12.9.118.15	SECTION 447.520	447.520 Federal Financial Participation (FFP): Conditions relating to physician-administered drugs.
42:4.0.1.1.12.9.118.16	SECTION 447.522	447.522 Optional coverage of investigational drugs and other drugs not subject to rebate.

---